GIA
INFI

Gargoyle Investment Advisor’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Gargoyle Investment Advisor’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-23,546
Closed -$199K – 182
2015
Q3 		$199K Hold
23,546
– – 0.08% 160
2015
Q2 		$258K Sell
23,546
-13,200
-36% -$169K 0.1% 161
2015
Q1 		$514K Hold
36,746
– – 0.19% 135
2014
Q4 		$621K Buy
+36,746
New +$535K 0.23% 111

Other funds holding INFI

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gargoyle Investment Advisor's INFI Position: Q4 2015 in Review

Gargoyle Investment Advisor sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2015, closing a stake of 23,546 shares — an estimated $199K sold.

Gargoyle Investment Advisor first reported a position in INFI in Q4 2014 and held it in 4 quarters. The position peaked at $621K in Q4 2014. 115 funds tracked by Wall St. Rank hold INFI as of Q4 2015.

  • Gargoyle Investment Advisor reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Gargoyle Investment Advisor sold 23,546 Infinity Pharmaceuticals, Inc. shares in Q4 2015, an estimated $199K.
  • Gargoyle Investment Advisor first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 4 quarters.
  • Gargoyle Investment Advisor's Infinity Pharmaceuticals, Inc. position peaked at $621K in Q4 2014.
  • 115 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2015.

Based on Gargoyle Investment Advisor's 13F filing for Q4 2015, filed 27 Jan 2016.